William Blair starts coverage on Waters with an Outperform rating, saying the BD merger could drive strong earnings growth ...
Merck cholesterol pill enlicitide and cancer therapy sac-TMT tapped for new priority program FDA expects Merck to submit applications in April and autumn of 2026, documents show Both drugs if approved ...
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Pharmaceutical giant Merck will close its plant in Northumberland County, Pennsylvania. According to a WARN ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
Merck & Co., Inc.'s (NYSE:MRK) dividend will be increasing from last year's payment of the same period to $0.85 on 8th of January. This will take the dividend yield to an attractive 3.4%, providing a ...
If you are wondering whether Merck is still attractively priced today, or if the market has already priced in much of the potential upside, this is a good place to dig into what the numbers may ...
Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's (MRK.N), opens new tab cholesterol pill and its cancer therapy, making them ...
The Merck Future Insight prize was established on the occasion of Merck’s 350th anniversary in 2018 to honour and enable pioneering scientists who are striving to solve some of the biggest challenges ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.
Pimelonitrile — a linear aliphatic dinitrile — has become an indispensable intermediate used in the synthesis of antiviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results